Page 382 - Read Online

Mura et al. The peritoneal metastases from GC

24. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, with peritoneal metastasis from gastric cancer. Gastric Cancer
Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Genève J, 2010;13:101-8.
Lasser P, Rougier P. Perioperative chemotherapy compared with 38. Ishizone S, Maruta F, Saito H, Koide N, Sugiyama A, Nakayama J,
surgery alone for resectable gastroesophageal adenocarcinoma: Miyagawa S. Efficacy of S-1 for patients with peritoneal metastasis of
an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol gastric cancer. Chemotherapy 2006;52:301-7.
2011;29:1715-21. 39. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29-42.
25. Xiong BH, Cheng Y, Ma L, Zhang CQ. An updated meta-analysis 40. Mura G, Federici O, Garofalo A. Hyperthermic Intraperitoneal
of randomized controlled trial assessing the effect of neoadjuvant Chemotherapy in Gastric Cancer: Indications and Technical Notes.
chemotherapy in advanced gastric cancer. Cancer Invest 2014;32:2 72-84. In: Iascone C, Paliotta A, Femia S, editors. Surgery in Multimodal
26. Cao J, Qi F, Liu T. Adjuvant chemotherapy after curative resection for Management of Gastric Cancer, Berlin: Springer-Verlag; 2012. p.107-12.
gastric cancer: a meta-analysis. Scand J Gastroenterol 2014;49:690-704. 41. Giovanella BC, Stehlin JS Jr, Morgan AC. Selective lethal effect
27. Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, of supranormal temperature on human neoplastic cells. Cancer Res
Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, 1976;36:3944-50.
Stemmermann GN, Blanke CD, Macdonald JS. Updated analysis of 42. Wallner KE, Banda M, Li GC. Hyperthermic enhancement of cell
SWOG-directed intergroup study 0116: a phase III trial of adjuvant killing by mitomycin C in mitomycin C-resistent Chinese hamster
radiochemotherapy versus observation after curative gastric cancer ovary cells. Cancer Res 1987;47:1308-12.
resection. J Clin Oncol 2012;30:2327-33. 43. Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E,
28. Liang JW, Zheng ZC, Yu T, Wang X, Zhang JJ. Is postoperative Schiller D. Treatment of gastric cancer with peritoneal carcinomatosis
adjuvant chemoradiotherapy efficacious and safe for gastric cancer by cytoreductive surgery and HIPEC: a systematic review of survival,
patients with D2 lymphadenectomy? A meta-analysis of the literature. mortality, and morbidity. J Surg Oncol 2011;104:692-8.
Eur J Surg Oncol 2014;40:1614-21. 44. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D,
29. Bilici A. Treatment options in patients with metastatic gastric Freyer G, François Y, Vignal J, Gilly FN. Cytoreductive surgery and
cancer: current status and future perspectives. World J Gastroenterol intraperitoneal chemohyperthermia for peritoneal carcinomatosis
2014;20:3905-15. arising from gastric cancer. Arch Surg 2004;139:20-6.
30. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, 45. Piso P, Slowik P, Popp F, Dahlke MH, Glockzin G, Schlitt HJ. Safety
Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani of gastric resections during cytoreductive surgery and hyperthermic
JA; V325 Study Group. Phase III study of docetaxel and cisplatin intraperitoneal chemotherapy for peritoneal carcinomatosis. Ann Surg
plus fluorouracil compared with cisplatin and fluorouracil as first- Oncol 2009;16:2188-94.
line therapy for advanced gastric cancer: a report of the V325 Study 46. Mura G, Framarini M, Vagliasindi A, Cavaliere D, Tauceri F,
Group. J Clin Oncol 2006;24:4991-7. Solfrini G, Milandri C, Verdecchia GM. Preliminary experience with
31. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, hyperthermic intraperitoneal chemo-perfusion with oxaliplatin for the
Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie treatment of peritoneal carcinomatosis due to colorectal carcinoma.
T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M. S-1 plus Chir Ital 2007;59:217-23.
cisplatin versus S-1 alone for first-line treatment of advanced gastric 47. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M,
cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008;9:215-21. Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N. Intraperitoneal
32. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki hyperthermic perfusion combined with surgery effective for gastric
A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, cancer patients with peritoneal seeding. Ann Surg 1988;208:36-41.
Lehle M, Rüschoff J, Kang YK; ToGA Trial Investigators. Trastuzumab 48. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T,
in combination with chemotherapy versus chemotherapy alone for Katayama K, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I.
treatment of HER2-positive advanced gastric or gastro-oesophageal Hyperthermochemotherapy combined with cytoreductive surgery for
junction cancer (ToGA): a phase 3, open-label, randomised controlled treatment of gastric cancer with peritoneal dissemination. World J
trial. Lancet 2010;376:687-97. Surg 1991;15:530-5.
33. Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, Kurteva 49. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T,
G, Volovat C, Moiseyenko VM, Gorbunova V, Park JO, Sawaki A, Isawa E, Sumida M, Ohkubo H. Improved mortality rate of gastric
Celik I, Götte H, Melezínková H, Moehler M; Arbeitsgemeinschaft carcinoma patients with peritoneal carcinomatosis treated with
Internistische Onkologie and EXPAND Investigators. Capecitabine intraperitoneal hyperthermic chemoperfusion combined with surgery.
and cisplatin with or without cetuximab for patients with previously Cancer 1997;79:884-91.
untreated advanced gastric cancer (EXPAND): a randomised, open- 50. Hirose K, Katayama K, Iida A, Yamaguchi A, Nakagawara G,
label phase 3 trial. Lancet Oncol 2013;14:490-9. Umeda S, Kusaka Y. Efficacy of continuous hyperthermic peritoneal
34. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper perfusion for the prophylaxis and treatment of peritoneal metastasis
P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A. of advanced gastric cancer: evaluation by multivariate regression
Prospective randomized trial comparing mitomycin, cisplatin, and analysis. Oncology 1999;57:106-14.
protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, 51. Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, McQuellon R,
cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Geisinger KR, Levine EA. Cytoreductive surgery with intraperitoneal
Oncol 2002;20:1996-2004. hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest
35. Baba H, Yamamoto M, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura Surg 2004;8:454-63.
T. Clinical efficacy of S-1 combined with cisplatin for advanced 52. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki
gastric cancer. Gastric Cancer 2003;6 Suppl 1:45-9. N. Treatment of peritoneal dissemination from gastric cancer by
36. Jacquet P, Sugarbaker PH. Peritoneal-plasma barrier. Cancer Treat peritonectomy and chemohyperthermic peritoneal perfusion. Br J
Res 1996;82:53-63. Surg 2005;92:370-5.
37. Tamura S, Miki H, Okada K, Takeno A, Uji K, Yoshida A, Suzuki R, 53. Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B,
Nakahira S, Egawa C, Nakata K, Okamura S, Sugimoto K, Takatsuka Parmentier G, Hay JM, Flamant Y, Msika S. Advanced gastric cancer
Y. Pilot study of a combination of S-1 and paclitaxel for patients with or without peritoneal carcinomatosis treated with hyperthermic
372 Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ September 18, 2016